"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"p53 signaling pathway"	66	4.3878	0.025713	0.073166	-4.2548	0.97334	1	16.728	0.00013955	0.00055997	35	14.495	0.0017436	0.0069969	31	9.0059	0.033588	0.14017
"2"	"mTOR signaling pathway"	147	0.26239	0.33722	0.60315	-0.26254	0.68916	1	18.143	0.011329	0.025149	76	11.955	0.4215	0.64476	71	13.738	0.001645	0.017162
"3"	"mRNA surveillance pathway"	88	5.0526	0.011028	0.034176	-4.854	0.98827	1	12.925	0.084926	0.14605	47	13.574	0.019563	0.051408	40	5.7556	0.55383	0.71632
"4"	"cGMP-PKG signaling pathway"	162	-0.89883	0.49518	0.7599	0.8987	0.53743	1	17.698	0.025878	0.051591	70	13.975	0.10036	0.20953	92	11.295	0.14298	0.31967
"5"	"cAMP signaling pathway"	185	1.4677	0.17602	0.36247	-1.4011	0.83527	1	18.317	0.043931	0.083335	89	14.701	0.15759	0.29691	96	11.273	0.15182	0.33702
"6"	"beta-Alanine metabolism"	31	-7.2634	0.99703	1	7.2634	0.0034266	0.042901	12.573	0.0015274	0.0043461	10	4.7747	0.41838	0.64476	21	11.981	0.00011589	0.0022672
"7"	"alpha-Linolenic acid metabolism"	22	-2.4479	0.80742	1	2.4479	0.19707	0.91563	2.9668	0.83258	0.89552	9	0.728	0.92	0.98367	13	3.2537	0.54054	0.70416
"8"	"Wnt signaling pathway"	139	-1.1999	0.55635	0.7988	1.1999	0.47392	1	12.238	0.55211	0.66466	71	6.6122	0.97435	0.9975	68	10.74	0.076538	0.2347
"9"	"Vitamin digestion and absorption"	23	-3.0063	0.86792	1	3.0063	0.14173	0.73934	7.7295	0.11015	0.18145	9	4.2807	0.45669	0.67039	14	6.4751	0.078913	0.23563
"10"	"Vitamin B6 metabolism"	8	-1.0077	0.62739	0.86891	1.0077	0.38133	1	4.4727	0.2363	0.33466	3	3.4972	0.28543	0.50856	5	2.9486	0.33515	0.54145
"11"	"Viral myocarditis"	71	6.1632	0.0027544	0.0091717	-6.1646	0.99734	1	9.5058	0.39968	0.50932	43	9.1538	0.40815	0.64091	28	3.7932	0.72935	0.87438
"12"	"Viral carcinogenesis"	209	10.782	2.1551e-06	1.2728e-05	-10.647	1	1	23.215	0.00021349	0.00079436	115	23.472	2.0286e-05	0.00013627	94	8.6542	0.6101	0.77627
"13"	"Vasopressin-regulated water reabsorption"	42	4.1098	0.040425	0.10457	-4.007	0.95861	1	9.5882	0.11423	0.18525	24	9.0296	0.11658	0.23857	18	4.2198	0.45404	0.63163
"14"	"Vascular smooth muscle contraction"	122	-0.069595	0.4251	0.70774	0.069436	0.60248	1	13.26	0.23196	0.33152	50	11.87	0.13029	0.25973	72	7.3682	0.64475	0.80722
"15"	"Valine, leucine and isoleucine degradation"	53	-18.513	1	1	18.513	5.0393e-13	4.8216e-11	18.067	2.8534e-06	1.7176e-05	6	2.0906	0.66442	0.81795	47	18.438	9.4726e-10	4.2356e-08
"16"	"Valine, leucine and isoleucine biosynthesis"	3	1.0161	0.31792	0.57593	-1.0161	0.68817	1	4.0481	0.1575	0.24898	1	4.709	0.06898	0.15225	2	1.6281	0.43966	0.62269
"17"	"VEGF signaling pathway"	55	10.243	2.5381e-06	1.4712e-05	-9.5776	0.99999	1	15.093	0.0006184	0.001963	34	15.815	0.00017926	0.00095503	21	4.3024	0.51639	0.68778
"18"	"Ubiquitin mediated proteolysis"	136	-1.9934	0.70151	0.9482	1.9934	0.33105	1	16.035	0.05023	0.093132	65	10.067	0.60099	0.77702	71	12.56	0.0093062	0.054959
"19"	"Ubiquinone and other terpenoid-quinone biosynthesis"	10	-5.6907	0.98723	1	5.6907	0.014075	0.12957	7.7937	0.028137	0.055389	2	2.9925	0.3041	0.52768	8	7.2173	0.010217	0.057155
"20"	"Tyrosine metabolism"	37	-4.0472	0.9324	1	4.0472	0.071687	0.5071	8.0183	0.25085	0.34897	12	4.4622	0.54322	0.74273	25	6.6632	0.15672	0.34304
"21"	"Type II diabetes mellitus"	45	-2.0215	0.75469	0.99665	2.0215	0.2614	1	11.598	0.02348	0.047414	17	8.8173	0.076232	0.16706	28	7.8326	0.085771	0.24186
"22"	"Type I diabetes mellitus"	53	2.9559	0.089516	0.20754	-2.9568	0.91648	1	2.5967	0.98622	1	29	3.6422	0.93778	0.99238	24	-0.14481	0.99327	1
"23"	"Tuberculosis"	159	16.035	8.8557e-12	1.6305e-10	-15.875	1	1	26.24	1.5459e-09	3.0241e-08	104	25.635	7.1463e-09	1.0515e-07	55	9.3644	0.096033	0.25691
"24"	"Tryptophan metabolism"	44	-11.661	0.99999	1	11.661	9.8492e-06	0.00030828	9.188	0.16375	0.25499	9	-1.258	0.98782	0.9975	35	10.94	0.0042027	0.029232
"25"	"Transcriptional misregulation in cancer"	165	9.266	1.8987e-05	8.7397e-05	-9.0924	0.99998	1	19.542	0.003313	0.0084998	96	18.84	0.0036496	0.013587	69	7.9963	0.46276	0.63808
"26"	"Toxoplasmosis"	106	10.046	7.8301e-06	3.8294e-05	-9.8829	0.99999	1	19.919	4.1081e-05	0.00019482	65	18.549	0.00039064	0.0018861	41	8.6729	0.092031	0.24832
"27"	"Toll-like receptor signaling pathway"	86	13.337	5.0915e-09	4.8292e-08	-13.337	1	1	18.973	1.0064e-05	5.4313e-05	57	19.614	1.5971e-05	0.00011216	29	5.1742	0.49927	0.67069
"28"	"Tight junction"	160	9.6523	1.0182e-05	4.9031e-05	-9.2658	0.99998	1	24.408	5.5475e-07	4.0381e-06	86	23.537	1.6771e-07	1.7869e-06	74	10.517	0.12267	0.29533
"29"	"Thyroid hormone synthesis"	72	0.58353	0.31833	0.57593	-0.43438	0.67634	1	9.4851	0.4028	0.51043	31	8.6677	0.29187	0.51167	41	5.0325	0.69616	0.85786
"30"	"Thyroid hormone signaling pathway"	114	3.1489	0.050951	0.12657	-3.1488	0.95407	1	21.221	3.8276e-06	2.2605e-05	65	15.504	0.019632	0.051408	49	14.512	4.2994e-05	0.0010352
"31"	"Thyroid cancer"	28	4.1189	0.040397	0.10457	-3.8731	0.95154	1	10.706	0.011071	0.024751	14	10.612	0.0076235	0.024797	14	4.5282	0.3273	0.54145
"32"	"Thiamine metabolism"	13	-4.7282	0.97022	1	4.7282	0.031934	0.26304	6.7496	0.094884	0.16053	5	1.7824	0.70787	0.83485	8	7.195	0.010527	0.057806
"33"	"Th17 cell differentiation"	97	5.0321	0.0095219	0.030105	-4.4172	0.9838	1	16.447	0.0030058	0.0080411	52	14.686	0.012445	0.036341	45	8.3602	0.16309	0.34726
"34"	"Th1 and Th2 cell differentiation"	84	3.4085	0.066045	0.15902	-2.7482	0.90227	1	12.967	0.069682	0.12463	44	11.382	0.1296	0.25973	40	6.8527	0.33356	0.54145
"35"	"Terpenoid backbone biosynthesis"	21	-3.3694	0.89605	1	3.3694	0.11664	0.68885	5.4505	0.4003	0.50932	8	2.0248	0.77078	0.8757	13	5.3392	0.17574	0.35718
"36"	"Taurine and hypotaurine metabolism"	10	1.5459	0.26213	0.4913	-1.5459	0.74214	1	2.8782	0.56838	0.67902	6	2.7281	0.55493	0.74457	4	1.2096	0.64068	0.80536
"37"	"Taste transduction"	54	-4.7255	0.96014	1	4.7255	0.047368	0.36161	5.766	0.81801	0.88901	14	3.7091	0.71089	0.83523	40	4.5052	0.78226	0.90274
"38"	"TNF signaling pathway"	105	19.966	0	0	-19.591	1	1	27.234	2.9521e-13	1.848e-11	71	28.55	3.2085e-14	2.4786e-12	34	6.6013	0.30085	0.51727
"39"	"TGF-beta signaling pathway"	80	9.9582	4.0609e-06	2.1544e-05	-9.8374	0.99999	1	14.311	0.013164	0.028813	50	15.231	0.0044798	0.016479	30	3.7067	0.7764	0.90274
"40"	"T cell receptor signaling pathway"	100	9.1933	3.902e-05	0.00016963	-9.1935	0.99997	1	18.463	0.00021572	0.00079436	61	17.424	0.0011498	0.005004	39	7.7733	0.17091	0.35193
"41"	"Systemic lupus erythematosus"	120	-2.7609	0.80862	1	2.9449	0.19891	0.91563	2.0183	0.99999	1	37	6.5004	0.75634	0.87205	77	3.6269	0.99092	1
"42"	"Synthesis and degradation of ketone bodies"	9	-4.1358	0.94534	1	4.1358	0.056947	0.41452	1.8341	0.7006	0.79452	0	NA	NA	NA	9	1.8341	0.71202	0.86719
"43"	"Synaptic vesicle cycle"	59	0.40741	0.3748	0.65173	-0.40741	0.6415	1	7.4005	0.62342	0.72271	31	5.0068	0.84956	0.92761	28	5.4743	0.41589	0.60829
"44"	"Sulfur relay system"	7	-2.9075	0.87841	1	2.9075	0.12646	0.70681	8.8241	0.0035053	0.008848	3	4.4604	0.16044	0.30046	4	7.8104	0.0026309	0.02167
"45"	"Sulfur metabolism"	10	-7.1036	0.99739	1	7.1036	0.0029736	0.039683	7.9914	0.02315	0.047052	2	1.4151	0.56769	0.74964	8	8.2271	0.002342	0.02156
"46"	"Steroid hormone biosynthesis"	85	0.04051	0.40572	0.69016	-0.04051	0.61744	1	-0.2695	1	1	35	1.9671	0.99407	1	49	-0.84463	0.9999	1
"47"	"Steroid biosynthesis"	18	2.2829	0.16167	0.33735	-2.2358	0.83691	1	5.2979	0.35216	0.45927	8	6.0261	0.13833	0.26884	10	1.718	0.7347	0.87438
"48"	"Starch and sucrose metabolism"	32	-1.9624	0.75892	0.99665	1.9624	0.25418	1	8.7671	0.10073	0.16951	10	7.8221	0.063336	0.1439	22	5.2999	0.3407	0.54352
"49"	"Staphylococcus aureus infection"	47	11.54	3.9239e-07	2.7293e-06	-11.25	1	1	19.74	1.0109e-08	1.5821e-07	29	19.83	2.4826e-08	3.1823e-07	18	6.7289	0.091764	0.24832
"50"	"Spliceosome"	127	13.269	1.5248e-08	1.4037e-07	-13.12	1	1	16.418	0.022069	0.045445	87	17.739	0.010512	0.031846	39	4.4477	0.77634	0.90274
"51"	"Sphingolipid signaling pathway"	117	10.461	4.4984e-06	2.3466e-05	-10.275	0.99999	1	22.684	4.7506e-07	3.7007e-06	71	20.886	1.3446e-05	9.6894e-05	46	10.229	0.033352	0.14017
"52"	"Sphingolipid metabolism"	44	3.7571	0.048367	0.12252	-3.4525	0.94179	1	9.6891	0.11412	0.18525	27	7.9686	0.30568	0.52768	17	5.5453	0.22569	0.42812
"53"	"Small cell lung cancer"	81	7.9202	0.00044146	0.0017272	-7.6183	0.99942	1	19.015	1.2527e-05	6.535e-05	48	17.174	8.35e-05	0.00048682	33	9.0785	0.031832	0.13776
"54"	"Signaling pathways regulating pluripotency of stem cells"	133	7.0956	0.00070618	0.0026631	-7.0957	0.99936	1	10.548	0.77118	0.84993	75	11.895	0.41165	0.64091	58	2.4466	0.99042	1
"55"	"Serotonergic synapse"	122	-0.71131	0.5257	0.76672	1.9824	0.31235	1	14.338	0.11414	0.18525	51	11.995	0.15178	0.28951	71	8.6288	0.34577	0.5466
"56"	"Selenocompound metabolism"	16	-2.0652	0.76719	0.99665	2.5585	0.18209	0.87686	8.0789	0.053333	0.097054	7	4.2585	0.38823	0.63138	9	7.0162	0.017705	0.085256
"57"	"Salmonella infection"	76	16.941	4.1078e-14	1.4286e-12	-16.582	1	1	23.405	2.4469e-10	7.5141e-09	53	23.83	1.2635e-09	2.7887e-08	23	6.3716	0.16532	0.3478
"58"	"Salivary secretion"	74	-0.89283	0.56162	0.80268	0.89283	0.45792	1	4.6714	0.97757	1	34	3.2072	0.98086	0.9975	40	3.3969	0.91167	0.97723
"59"	"SNARE interactions in vesicular transport"	31	0.54585	0.36621	0.64035	-0.54585	0.64786	1	6.5258	0.38334	0.49581	17	4.4213	0.69362	0.82753	14	4.8386	0.27383	0.49021
"60"	"Ribosome biogenesis in eukaryotes"	77	18.138	3.9646e-13	9.5456e-12	-17.991	1	1	21.238	2.3587e-08	2.8395e-07	55	23.141	5.627e-09	9.9075e-08	22	3.1444	0.74427	0.87908
"61"	"Ribosome"	128	7.3695	0.00055238	0.0021345	-7.3695	0.99946	1	23.389	2.3963e-07	2.143e-06	86	17.67	0.0064705	0.022216	42	15.547	7.9932e-07	2.2744e-05
"62"	"Riboflavin metabolism"	7	-4.9416	0.97846	1	4.9416	0.023257	0.20798	4.3696	0.24531	0.34465	1	0.58482	0.61521	0.78745	6	4.481	0.13052	0.3004
"63"	"Rheumatoid arthritis"	77	10.442	1.4119e-05	6.5961e-05	-10.441	0.99999	1	14.467	0.0084479	0.019443	51	14.852	0.012467	0.036341	26	4.0955	0.66511	0.82611
"64"	"Retrograde endocannabinoid signaling"	133	-9.9546	0.99991	1	10.039	0.00012423	0.0029911	17.343	0.011473	0.02529	41	8.3107	0.51547	0.72072	92	15.304	0.0011756	0.013629
"65"	"Retinol metabolism"	86	-2.8073	0.80808	1	2.8073	0.21087	0.93635	6.5459	0.93382	0.9908	28	6.6053	0.55774	0.74457	57	4.4984	0.9174	0.98002
"66"	"Renin-angiotensin system"	27	-4.4007	0.95258	1	4.4007	0.05394	0.40198	3.0377	0.86085	0.91961	4	2.3014	0.55566	0.74457	23	2.3315	0.86241	0.94054
"67"	"Renin secretion"	65	-2.7367	0.813	1	2.7367	0.20503	0.93005	7.6146	0.63594	0.72931	26	5.5294	0.68603	0.82717	38	6.7169	0.30041	0.51727
"68"	"Renal cell carcinoma"	63	10.534	3.3603e-06	1.8781e-05	-10.534	1	1	19.215	7.0687e-07	4.8098e-06	43	17.437	8.0604e-05	0.00047897	20	8.5352	0.011984	0.062515
"69"	"Regulation of lipolysis in adipocytes"	52	0.021767	0.45148	0.73219	0.11339	0.54791	1	7.7077	0.49694	0.60759	25	5.8459	0.62103	0.78745	27	5.0713	0.45712	0.6331
"70"	"Regulation of actin cytoskeleton"	207	22.306	0	0	-21.943	1	1	34.136	0	0	136	34.363	0	0	71	10.727	0.074776	0.2347
"71"	"Ras signaling pathway"	218	12.061	3.0236e-08	2.6289e-07	-11.831	1	1	23.593	0.00027713	0.00098042	132	22.285	0.00076654	0.0034833	86	9.9542	0.26772	0.48718
"72"	"Rap1 signaling pathway"	206	15.286	2.7475e-11	4.2998e-10	-15.037	1	1	28.391	1.184e-09	2.4706e-08	123	28.135	2.3383e-09	4.8169e-08	83	10.478	0.17989	0.36327
"73"	"RNA transport"	161	12.577	2.652e-08	2.3717e-07	-12.391	1	1	22.572	2.0167e-05	0.0001002	94	23.774	6.8245e-07	6.2023e-06	66	7.8924	0.45008	0.63163
"74"	"RNA polymerase"	28	2.2042	0.16085	0.33735	-2.2042	0.84448	1	8.8456	0.073765	0.13044	15	7.5842	0.1444	0.27887	13	4.8351	0.24765	0.46022
"75"	"RNA degradation"	75	2.7371	0.096101	0.21774	-2.5232	0.89451	1	14.276	0.014888	0.031917	39	11.983	0.050864	0.11817	36	8.1331	0.10748	0.28013
"76"	"RIG-I-like receptor signaling pathway"	54	8.2839	0.00012583	0.00051148	-8.2839	0.99986	1	11.23	0.05277	0.096591	34	12.197	0.025567	0.065292	20	2.5495	0.803	0.90511
"77"	"Pyruvate metabolism"	36	-10.864	0.99998	1	10.864	2.4319e-05	0.00069198	11.916	0.0054143	0.013137	7	2.514	0.67856	0.8255	29	12.042	0.00033564	0.0047752
"78"	"Pyrimidine metabolism"	100	2.4235	0.11717	0.25828	-1.6176	0.81898	1	18.549	0.00018681	0.00070449	49	15.109	0.0058401	0.020276	51	11.164	0.013662	0.067877
"79"	"Purine metabolism"	173	-3.4374	0.86734	1	3.4374	0.15397	0.78651	20.829	0.000852	0.0025864	72	14.319	0.085556	0.18487	101	15.17	0.001525	0.016459
"80"	"Proximal tubule bicarbonate reclamation"	21	-3.7456	0.92112	1	3.7456	0.089866	0.57404	7.0771	0.15155	0.24078	8	3.3161	0.56003	0.74457	13	6.3934	0.072946	0.2347
"81"	"Proteoglycans in cancer"	197	16.607	3.6005e-13	9.3912e-12	-16.014	1	1	31.94	1.7653e-14	1.8417e-12	116	31.505	1.1213e-14	1.155e-12	81	12.109	0.039574	0.15483
"82"	"Protein processing in endoplasmic reticulum"	157	10.757	8.2031e-07	5.3491e-06	-10.623	1	1	20.989	0.0001569	0.00061387	102	18.926	0.007029	0.023637	55	9.688	0.070005	0.2331
"83"	"Protein export"	25	2.4367	0.14103	0.29825	-2.4367	0.86625	1	5.552	0.45476	0.56261	17	3.8678	0.77339	0.8757	8	4.1765	0.21669	0.4161
"84"	"Protein digestion and absorption"	85	3.1712	0.067841	0.16209	-3.1712	0.93837	1	11.387	0.23612	0.33466	42	11.325	0.10547	0.21728	43	4.8172	0.79191	0.90463
"85"	"Proteasome"	45	4.0752	0.037561	0.10135	-4.0752	0.96464	1	6.2599	0.63856	0.72945	27	6.5515	0.54941	0.74457	18	1.8738	0.84617	0.93257
"86"	"Prostate cancer"	85	6.5351	0.0022632	0.0079377	-6.5353	0.99799	1	16.49	0.0014177	0.0041086	50	14.874	0.0070374	0.023637	35	7.9195	0.12455	0.29533
"87"	"Propanoate metabolism"	30	-17.727	1	1	17.727	6.1617e-13	4.8216e-11	17.059	3.8901e-07	3.122e-06	3	0.24992	0.80756	0.90782	27	17.898	2.6309e-11	3.8562e-09
"88"	"Prolactin signaling pathway"	67	4.0788	0.034004	0.094187	-4.0789	0.96893	1	12.197	0.050285	0.093132	36	10.998	0.097097	0.2055	31	6.0791	0.36386	0.56432
"89"	"Progesterone-mediated oocyte maturation"	81	-0.29476	0.43839	0.72601	1.7461	0.36319	1	10.819	0.2834	0.38309	34	9.3024	0.2562	0.46027	47	6.2909	0.54218	0.70416
"90"	"Prion diseases"	33	6.2937	0.0033827	0.011145	-6.069	0.99563	1	12.295	0.0033082	0.0084998	19	12.159	0.0028685	0.010943	14	4.7114	0.29522	0.51336
"91"	"Primary immunodeficiency"	34	4.0807	0.034794	0.095532	-4.0807	0.96668	1	4.853	0.72481	0.81314	23	4.8234	0.77368	0.8757	11	1.5574	0.77839	0.90274
"92"	"Primary bile acid biosynthesis"	15	-0.55764	0.52911	0.76672	0.55764	0.47847	1	6.1844	0.19145	0.28672	8	3.6064	0.50732	0.71581	7	5.1976	0.088491	0.24597
"93"	"Porphyrin and chlorophyll metabolism"	40	-6.0788	0.99045	1	8.1707	0.00078837	0.012987	6.2841	0.57164	0.67961	11	2.8597	0.72754	0.84833	28	7.2699	0.13747	0.30956
"94"	"Platinum drug resistance"	75	0.13634	0.39529	0.67981	-0.13634	0.62288	1	16.437	0.0010053	0.0029683	34	12.719	0.014499	0.041751	41	10.649	0.0099571	0.057155
"95"	"Platelet activation"	119	10.565	2.908e-06	1.6549e-05	-10.565	1	1	19.805	0.00010381	0.00042754	70	19.992	5.6563e-05	0.00034271	49	6.9685	0.4325	0.62097
"96"	"Phototransduction"	25	2.0307	0.18008	0.3684	-2.0301	0.82838	1	4.2102	0.68841	0.78353	13	4.3273	0.56144	0.74457	12	1.573	0.80586	0.90511
"97"	"Phosphonate and phosphinate metabolism"	5	-3.6333	0.92661	1	3.6333	0.077442	0.52694	3.357	0.33035	0.43583	1	1.0617	0.53487	0.73456	4	3.2224	0.27408	0.49021
"98"	"Phospholipase D signaling pathway"	141	9.4951	5.4751e-06	2.764e-05	-9.0892	0.99999	1	20.179	0.00028191	0.00098042	80	19.774	0.00034453	0.0016898	61	8.0339	0.39236	0.5876
"99"	"Phosphatidylinositol signaling system"	94	2.3144	0.12638	0.27663	-2.3144	0.88488	1	8.77	0.74464	0.82944	51	7.4148	0.82055	0.91534	43	4.8916	0.78132	0.90274
"100"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	6	-1.3174	0.68728	0.93938	1.3174	0.32345	1	-1.6505	0.97404	1	2	-2.5039	0.9691	0.9975	4	-0.25094	0.85485	0.93555
"101"	"Phenylalanine metabolism"	21	-0.3524	0.5118	0.76672	0.3524	0.50328	1	5.3375	0.42131	0.53174	9	4.1743	0.4747	0.68471	12	3.4457	0.47184	0.6435
"102"	"Phagosome"	161	17.124	1.4488e-13	4.5349e-12	-16.837	1	1	22.129	4.7474e-05	0.00022178	105	23.418	8.9735e-06	6.9321e-05	56	5.4551	0.78449	0.90274
"103"	"Pertussis"	71	11.931	1.1845e-07	9.0423e-07	-11.929	1	1	20.358	3.3662e-07	2.7727e-06	42	21.146	4.9052e-09	9.4731e-08	29	6.4071	0.27024	0.48893
"104"	"Peroxisome"	82	-15.579	1	1	15.579	2.146e-09	1.1195e-07	17.564	0.00027171	0.00097752	15	5.2765	0.47642	0.68471	67	16.934	1.2256e-06	3.1969e-05
"105"	"Pentose phosphate pathway"	29	2.3873	0.12895	0.2803	-2.3873	0.87639	1	8.9769	0.065849	0.1186	16	7.4839	0.16693	0.30903	13	5.105	0.20734	0.40817
"106"	"Pentose and glucuronate interconversions"	33	-1.6514	0.70282	0.9482	1.6514	0.31446	1	4.8776	0.73048	0.81657	15	3.6298	0.74396	0.86422	17	5.3773	0.25077	0.46171
"107"	"Pathways in cancer"	382	14.718	9.4849e-11	1.237e-09	-14.323	1	1	33.336	4.5123e-09	7.4335e-08	217	31.556	4.3377e-08	4.9643e-07	165	14.534	0.11317	0.28567
"108"	"Parkinson disease"	123	-19.244	1	1	19.244	1.0048e-13	1.5724e-11	22.439	5.5416e-07	4.0381e-06	24	5.579	0.64079	0.7984	99	22.265	1.169e-10	9.1471e-09
"109"	"Pantothenate and CoA biosynthesis"	17	-4.8646	0.9725	1	4.8646	0.031651	0.26304	7.1109	0.1041	0.17332	5	1.9073	0.68797	0.82717	12	7.2326	0.025115	0.1156
"110"	"Pancreatic secretion"	93	0.088632	0.40321	0.68964	-0.088632	0.61868	1	5.0206	0.99216	1	39	5.9611	0.8386	0.9226	53	2.6647	0.98499	1
"111"	"Pancreatic cancer"	63	6.454	0.0023422	0.008056	-6.4542	0.99785	1	15.313	0.00099038	0.0029523	38	13.572	0.011508	0.034192	25	7.5749	0.069873	0.2331
"112"	"PPAR signaling pathway"	79	1.3587	0.22498	0.43469	-1.3587	0.78788	1	10.859	0.27404	0.37456	40	8.4174	0.48076	0.68776	39	6.9311	0.30243	0.51727
"113"	"PI3K-Akt signaling pathway"	317	14.229	2.8123e-10	3.3855e-09	-13.228	1	1	34.067	1.1452e-12	5.1207e-11	178	32.217	2.9127e-11	9.0003e-10	139	14.989	0.026291	0.11926
"114"	"Oxytocin signaling pathway"	146	1.3764	0.19057	0.38239	-1.2956	0.82058	1	19.985	0.00060106	0.0019395	72	15.912	0.019103	0.051329	73	13.421	0.002626	0.02167
"115"	"Oxidative phosphorylation"	113	-21.8	1	1	21.8	1.1102e-16	3.475e-14	21.921	1.6272e-06	1.0394e-05	16	2.7949	0.85565	0.9277	97	22.525	3.696e-11	3.8562e-09
"116"	"Ovarian steroidogenesis"	52	-0.085135	0.46881	0.7525	0.22029	0.53087	1	6.5026	0.70986	0.80212	19	6.7546	0.32369	0.54956	33	3.0373	0.89959	0.96761
"117"	"Other types of O-glycan biosynthesis"	21	1.3478	0.25353	0.47805	-1.3478	0.75318	1	5.2889	0.43041	0.53888	12	5.242	0.40319	0.64091	8	5.0514	0.11029	0.28295
"118"	"Other glycan degradation"	15	-6.8412	0.9963	1	10.214	2.6969e-05	0.00070345	7.4825	0.074483	0.13097	2	2.0449	0.45928	0.67039	13	7.2354	0.030642	0.13508
"119"	"Osteoclast differentiation"	120	18.299	4.4409e-16	1.7375e-14	-18.288	1	1	25.651	7.6416e-11	2.6576e-09	84	25.639	6.9093e-09	1.0515e-07	36	7.6688	0.15788	0.34318
"120"	"Oocyte meiosis"	107	-0.30228	0.4506	0.73219	1.565	0.37647	1	15.908	0.014446	0.031182	43	13.497	0.018353	0.049746	64	9.505	0.16557	0.3478
"121"	"One carbon pool by folate"	18	1.6516	0.22855	0.43886	-1.6516	0.77598	1	8.4177	0.040481	0.077734	10	6.845	0.13486	0.26543	8	4.9736	0.11786	0.29513
"122"	"Olfactory transduction"	656	-6.4084	0.97563	1	6.4085	0.037329	0.29959	-7.5784	1	1	208	-4.6435	1	1	448	-6.0065	1	1
"123"	"Nucleotide excision repair"	42	-0.85524	0.58171	0.82387	0.85524	0.4341	1	8.7548	0.20015	0.29551	20	5.8325	0.53429	0.73456	22	6.5354	0.15334	0.33799
"124"	"Notch signaling pathway"	48	5.7107	0.0075153	0.024003	-5.7107	0.99299	1	9.4636	0.18051	0.27427	30	9.0263	0.20216	0.37184	18	3.801	0.53477	0.70035
"125"	"Non-small cell lung cancer"	57	4.834	0.015262	0.046832	-4.8342	0.98513	1	16.325	0.00013087	0.00053197	31	14.44	0.001171	0.0050138	26	8.4041	0.035202	0.14126
"126"	"Non-homologous end-joining"	11	-6.003	0.99281	1	6.003	0.0075643	0.081642	5.522	0.18838	0.28484	2	0.8079	0.66767	0.81869	9	5.724	0.07499	0.2347
"127"	"Non-alcoholic fatty liver disease (NAFLD)"	139	-7.6597	0.99779	1	7.6601	0.0030428	0.039683	26.634	2.6407e-10	7.5141e-09	48	17.014	0.00011176	0.00062787	91	20.56	1.261e-09	4.9336e-08
"128"	"Nitrogen metabolism"	16	-0.13944	0.47724	0.75604	0.13944	0.53087	1	5.5566	0.29548	0.39355	7	4.3206	0.37806	0.62139	9	3.5983	0.36419	0.56432
"129"	"Nicotine addiction"	35	-3.1751	0.87054	1	3.1751	0.1383	0.73368	1.2926	0.98722	1	13	-1.2136	0.9976	1	22	2.5632	0.82749	0.91845
"130"	"Nicotinate and nicotinamide metabolism"	32	-3.7731	0.92455	1	3.7731	0.082781	0.5398	9.9144	0.035737	0.069911	10	6.623	0.15686	0.29691	22	7.492	0.067353	0.23257
"131"	"Neurotrophin signaling pathway"	118	10.411	3.7731e-06	2.0719e-05	-10.35	1	1	23.357	1.1372e-07	1.1482e-06	72	21.394	3.4833e-06	2.909e-05	46	10.643	0.020754	0.098424
"132"	"Neuroactive ligand-receptor interaction"	238	1.0565	0.21734	0.42654	-0.96124	0.79826	1	7.6594	0.99993	1	101	8.9611	0.97192	0.9975	137	2.4012	1	1
"133"	"Neomycin, kanamycin and gentamicin biosynthesis"	4	2.051	0.19058	0.38239	-2.051	0.80545	1	3.4173	0.27846	0.37894	3	2.7299	0.41	0.64091	1	2.1064	0.28437	0.50287
"134"	"Natural killer cell mediated cytotoxicity"	99	10.595	1.5855e-06	9.9252e-06	-10.595	1	1	17.453	0.0010323	0.0030196	62	17.107	0.0014371	0.0058431	37	6.4052	0.36792	0.56728
"135"	"NOD-like receptor signaling pathway"	150	12.919	4.8108e-09	4.7055e-08	-12.704	1	1	23.486	1.9376e-06	1.213e-05	88	23.77	1.2582e-07	1.3885e-06	62	8.2119	0.37402	0.57106
"136"	"NF-kappa B signaling pathway"	93	17.532	6.7502e-13	1.5091e-11	-17.158	1	1	20.626	6.2951e-07	4.3786e-06	66	22.166	2.0449e-07	2.0383e-06	27	3.6249	0.73247	0.87438
"137"	"N-Glycan biosynthesis"	48	4.5617	0.024344	0.070552	-4.5617	0.97728	1	7.0128	0.56559	0.67827	33	6.9017	0.62435	0.78745	14	4.5831	0.31754	0.53435
"138"	"Mucin type O-glycan biosynthesis"	26	4.9791	0.017919	0.054454	-4.9791	0.98262	1	4.8952	0.5821	0.68496	16	5.8742	0.39343	0.63317	10	0.46286	0.8953	0.96631
"139"	"Morphine addiction"	87	-0.33218	0.47359	0.75604	0.33252	0.55	1	11.662	0.22496	0.32448	39	9.187	0.33809	0.57087	48	7.4188	0.3373	0.54145
"140"	"Mitophagy - animal"	61	-1.083	0.62483	0.86891	1.1992	0.37338	1	16.229	0.00028107	0.00098042	27	11.698	0.014931	0.042327	34	11.313	0.0021692	0.020588
"141"	"Mismatch repair"	21	-6.3082	0.993	1	6.3082	0.0091134	0.095083	6.8618	0.17697	0.27021	8	0.033818	0.95069	0.99319	13	8.6947	0.0047343	0.031704
"142"	"Mineral absorption"	42	2.4651	0.13585	0.29124	-2.4651	0.87119	1	8.8045	0.19414	0.28936	24	7.4345	0.31759	0.54218	18	4.8645	0.33451	0.54145
"143"	"MicroRNAs in cancer"	139	14.485	6.5944e-11	9.8288e-10	-13.829	1	1	25.22	1.1505e-08	1.6369e-07	89	24.354	2.5747e-08	3.1823e-07	50	9.5576	0.074895	0.2347
"144"	"Metabolism of xenobiotics by cytochrome P450"	63	-8.8876	0.99974	1	8.8876	0.00034526	0.0067542	9.8545	0.2503	0.34897	18	3.2232	0.85468	0.9277	44	10.968	0.010226	0.057155
"145"	"Metabolic pathways"	1265	-14.325	1	1	15.055	2.4388e-07	9.5416e-06	53.222	5.5833e-13	2.9126e-11	515	33.252	0.067998	0.15116	748	42.222	0	0
"146"	"Melanoma"	67	4.393	0.025652	0.073166	-4.3932	0.97662	1	14.02	0.0071117	0.016612	39	12.078	0.046646	0.11003	28	7.4323	0.12075	0.29533
"147"	"Melanogenesis"	96	2.979	0.065967	0.15902	-2.9792	0.93682	1	10.266	0.51126	0.62266	51	8.6135	0.65841	0.8138	45	5.8247	0.61448	0.77868
"148"	"Measles"	121	10.803	1.0459e-06	6.681e-06	-10.648	1	1	18.702	0.00069953	0.0021679	76	18.138	0.0011845	0.0050138	45	7.0962	0.36418	0.56432
"149"	"Maturity onset diabetes of the young"	19	-0.85797	0.60467	0.84959	0.85797	0.4095	1	-0.29912	0.98644	1	6	0.25467	0.89423	0.95943	13	-0.53463	0.9761	1
"150"	"Mannose type O-glycan biosynthesis"	22	-2.4317	0.8056	1	2.4317	0.19892	0.91563	7.9168	0.10721	0.17755	8	5.1815	0.24143	0.43627	14	6.0074	0.11888	0.29533
"151"	"Malaria"	46	16.079	8.3221e-11	1.1325e-09	-15.626	1	1	18.029	4.8476e-07	3.7007e-06	36	18.497	2.5198e-06	2.1628e-05	10	3.5725	0.38172	0.57999
"152"	"MAPK signaling pathway"	246	13.829	1.0437e-09	1.1667e-08	-13.38	1	1	28.389	5.9168e-08	6.6142e-07	144	27.854	2.8005e-08	3.3283e-07	101	11.864	0.10449	0.27716
"153"	"Lysosome"	120	-6.9773	0.99604	1	8.1698	0.0013664	0.019441	18.495	0.00085939	0.0025864	44	10.584	0.21929	0.39859	76	15.187	0.00019708	0.0030843
"154"	"Lysine degradation"	56	-4.227	0.92669	1	4.227	0.082174	0.5398	12.597	0.021695	0.044971	25	6.0869	0.58061	0.75699	31	11.465	0.0010499	0.012639
"155"	"Lysine biosynthesis"	1	-0.26771	0.52026	0.76672	0.26771	0.48282	1	-0.8027	0.79221	0.86398	0	NA	NA	NA	1	-0.8027	0.80968	0.90511
"156"	"Longevity regulating pathway - multiple species"	60	3.6651	0.048539	0.12252	-3.448	0.94516	1	15.568	0.00047484	0.0015482	30	13.954	0.0012453	0.0051998	30	8.0635	0.080306	0.23565
"157"	"Longevity regulating pathway"	88	2.6116	0.096697	0.21774	-2.6116	0.91322	1	16.242	0.0019565	0.0053719	41	14.455	0.0053127	0.018655	47	8.7234	0.13176	0.30081
"158"	"Long-term potentiation"	63	-0.63577	0.53246	0.76801	0.63555	0.48721	1	14.693	0.0024129	0.0065674	26	11.665	0.021766	0.05652	37	9.3939	0.034233	0.14098
"159"	"Long-term depression"	57	3.7986	0.040832	0.10476	-3.7988	0.96069	1	10.151	0.16633	0.25772	28	10.43	0.054374	0.12538	29	3.9823	0.72178	0.87227
"160"	"Lipoic acid metabolism"	2	0.34375	0.44634	0.73219	-0.34375	0.55767	1	0.2778	0.71856	0.80902	1	0.55734	0.61972	0.78745	1	-0.16448	0.71204	0.86719
"161"	"Linoleic acid metabolism"	46	-1.9757	0.72492	0.96966	1.9757	0.2921	1	1.4744	0.99595	1	17	0.82647	0.9817	0.9975	29	1.2241	0.97461	1
"162"	"Leukocyte transendothelial migration"	107	16.3	9.7272e-12	1.6915e-10	-16.086	1	1	22.255	2.8332e-07	2.3967e-06	67	24.336	5.7714e-09	9.9075e-08	40	4.9024	0.71739	0.87032
"163"	"Leishmaniasis"	64	16.528	1.4565e-11	2.3994e-10	-16.405	1	1	21.053	1.1257e-08	1.6369e-07	47	21.472	6.9871e-09	1.0515e-07	17	5.1466	0.28747	0.50409
"164"	"Legionellosis"	56	15.065	1.8307e-10	2.292e-09	-14.488	1	1	21.528	1.6535e-09	3.0445e-08	34	23.662	7.2276e-13	3.7222e-11	22	4.9302	0.40999	0.60686
"165"	"Jak-STAT signaling pathway"	133	8.9362	4.0325e-05	0.00017056	-8.2774	0.99989	1	19.493	0.00062089	0.001963	74	19.328	0.00028306	0.0014338	59	7.6211	0.42788	0.62003
"166"	"Intestinal immune network for IgA production"	40	6.3153	0.0027367	0.0091717	-6.3153	0.99747	1	7.034	0.43849	0.54681	24	8.5269	0.16702	0.30903	16	0.67852	0.93706	0.99106
"167"	"Insulin signaling pathway"	136	3.1843	0.060574	0.14812	-3.1846	0.94651	1	21.128	6.4286e-05	0.00027946	73	16.083	0.016348	0.045509	63	13.731	0.00093062	0.011651
"168"	"Insulin secretion"	80	-3.9539	0.91703	1	3.9543	0.097287	0.60902	11.568	0.15991	0.25136	31	7.3257	0.51283	0.72029	49	8.9548	0.12316	0.29533
"169"	"Insulin resistance"	106	5.6133	0.005689	0.018357	-5.613	0.99474	1	22.648	1.3474e-07	1.278e-06	61	18.226	0.00034282	0.0016898	45	13.539	0.00017054	0.0028094
"170"	"Inositol phosphate metabolism"	69	1.5233	0.21363	0.42589	-1.5233	0.80075	1	8.0996	0.62973	0.72733	36	6.8624	0.69222	0.82753	33	4.5444	0.69056	0.85432
"171"	"Influenza A"	150	14.531	7.0515e-11	1.0032e-09	-14.394	1	1	21.435	0.00010235	0.00042716	100	21.448	0.00016592	0.0009155	50	6.7939	0.47286	0.6435
"172"	"Inflammatory mediator regulation of TRP channels"	118	3.8387	0.039085	0.10368	-3.8384	0.96522	1	13.702	0.16833	0.25948	55	13.822	0.043407	0.10317	63	5.8378	0.79643	0.90511
"173"	"Inflammatory bowel disease (IBD)"	55	8.9322	3.0585e-05	0.00013676	-8.1158	0.99988	1	12.337	0.022266	0.045551	34	13.597	0.0049914	0.017934	21	2.6645	0.79818	0.90511
"174"	"IL-17 signaling pathway"	84	21.325	0	0	-20.899	1	1	23.013	1.0448e-09	2.3359e-08	61	25.747	1.4736e-11	5.0592e-10	23	2.0506	0.89153	0.96557
"175"	"Hypertrophic cardiomyopathy (HCM)"	81	3.8312	0.040287	0.10457	-3.6856	0.95892	1	20.278	8.9725e-07	5.9753e-06	42	17.384	2.9489e-05	0.00019387	38	12.661	0.00016275	0.0028094
"176"	"Huntingtons disease"	178	-13.521	1	1	13.521	5.2329e-07	1.8199e-05	23.531	1.4856e-05	7.5e-05	53	10.994	0.29309	0.51167	125	20.922	1.6871e-07	5.8673e-06
"177"	"Homologous recombination"	37	-3.1185	0.86919	1	3.1185	0.13763	0.73368	4.8864	0.74888	0.8312	16	1.4126	0.95141	0.99319	21	5.253	0.33733	0.54145
"178"	"Histidine metabolism"	24	-6.0662	0.98893	1	6.0662	0.012444	0.11803	9.6655	0.02163	0.044971	7	3.763	0.47146	0.68394	17	9.0696	0.0070775	0.043503
"179"	"Hippo signaling pathway -multiple species"	25	10.377	1.2334e-05	5.8493e-05	-10.377	0.99999	1	9.6634	0.024573	0.049304	21	10.481	0.025908	0.06562	4	0.14227	0.80779	0.90511
"180"	"Hippo signaling pathway"	150	11.898	5.5373e-08	4.444e-07	-11.898	1	1	18.437	0.0084033	0.019443	95	18.35	0.0089474	0.028502	55	6.3313	0.61806	0.78005
"181"	"Herpes simplex infection"	184	11.661	1.2252e-07	9.1306e-07	-11.661	1	1	17.916	0.052701	0.096591	112	18.978	0.015147	0.042549	71	5.9797	0.82163	0.91519
"182"	"Hepatitis C"	116	9.2213	2.4595e-05	0.00011157	-9.2213	0.99998	1	17.378	0.0044482	0.010877	69	17.247	0.0032807	0.012363	47	6.4042	0.51951	0.68901
"183"	"Hepatitis B"	130	13.413	4.187e-09	4.2275e-08	-13.393	1	1	24.031	2.3118e-08	2.8395e-07	82	23.149	6.2364e-07	5.8395e-06	48	9.292	0.088802	0.24597
"184"	"Hematopoietic cell lineage"	88	13.87	2.2975e-09	2.3971e-08	-12.714	1	1	20.584	5.6984e-07	4.0537e-06	56	21.122	4.4903e-07	4.3359e-06	32	6.1939	0.34209	0.54352
"185"	"Hedgehog signaling pathway"	43	2.7707	0.095694	0.21774	-2.7707	0.91049	1	8.1566	0.28395	0.38309	25	6.9615	0.42983	0.6479	18	4.4027	0.41918	0.61025
"186"	"HTLV-I infection"	264	12.557	6.6546e-08	5.2072e-07	-12.379	1	1	21.896	0.017039	0.035794	164	20.676	0.049188	0.11514	100	9.0988	0.57437	0.73679
"187"	"HIF-1 signaling pathway"	98	8.0678	0.00014566	0.0005845	-8.0677	0.99988	1	22.054	2.7001e-07	2.3476e-06	64	17.927	0.000567	0.0026546	34	12.846	0.00015282	0.0028094
"188"	"Graft-versus-host disease"	49	4.1773	0.026084	0.073552	-4.1783	0.97524	1	3.0161	0.97655	1	25	5.316	0.70491	0.83455	24	-1.1161	0.99847	1
"189"	"GnRH signaling pathway"	85	4.5589	0.020295	0.060498	-4.3941	0.97865	1	17.487	0.00030401	0.0010457	41	16.657	0.00024637	0.0012688	44	8.2259	0.16928	0.35193
"190"	"Glyoxylate and dicarboxylate metabolism"	28	-6.4087	0.99193	1	6.4087	0.010029	0.10126	8.1737	0.12608	0.20238	10	1.9927	0.84138	0.9226	18	8.7092	0.011053	0.058639
"191"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	23	-5.9617	0.98947	1	5.9617	0.012432	0.11803	9.6931	0.016126	0.034104	7	4.0593	0.4213	0.64476	16	8.9367	0.0034671	0.02713
"192"	"Glycosphingolipid biosynthesis - lacto and neolacto series"	26	3.1162	0.087861	0.20523	-3.1162	0.91516	1	8.5076	0.083099	0.1437	15	7.5658	0.14622	0.28063	11	4.2448	0.28828	0.50409
"193"	"Glycosphingolipid biosynthesis - globo and isoglobo series"	15	1.4982	0.21786	0.42654	-1.4982	0.78644	1	6.3779	0.16912	0.25948	7	6.1576	0.13614	0.26625	8	2.9734	0.43011	0.62038
"194"	"Glycosphingolipid biosynthesis - ganglio series"	14	1.0411	0.32089	0.57723	-1.0411	0.6868	1	7.9605	0.040439	0.077734	7	6.5343	0.10396	0.2156	7	4.7235	0.13263	0.30081
"195"	"Glycosaminoglycan degradation"	18	-3.4913	0.89326	1	3.4913	0.1139	0.68562	7.4708	0.091652	0.15591	6	4.291	0.28638	0.50856	12	6.1156	0.080558	0.23565
"196"	"Glycosaminoglycan biosynthesis - keratan sulfate"	12	4.2602	0.038058	0.10181	-4.2602	0.9639	1	9.8281	0.0031802	0.0083647	8	8.4172	0.014592	0.041751	4	5.1191	0.066047	0.23228
"197"	"Glycosaminoglycan biosynthesis - heparan sulfate / heparin"	23	1.2289	0.27785	0.51766	-1.2289	0.72756	1	6.5775	0.24555	0.34465	13	5.1261	0.40915	0.64091	10	4.1305	0.28089	0.49953
"198"	"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate"	19	9.3076	3.9986e-05	0.00017056	-9.0822	0.99994	1	8.0538	0.065931	0.1186	15	9.6442	0.025298	0.065143	4	-1.123	0.92973	0.98981
"199"	"Glycolysis / Gluconeogenesis"	62	-2.3094	0.77057	0.99665	2.4411	0.22615	0.98313	15.636	0.00072642	0.0022291	24	11.512	0.010463	0.031846	38	10.823	0.0040898	0.029093
"200"	"Glycine, serine and threonine metabolism"	39	-2.823	0.83435	1	2.989	0.15831	0.78651	9.2631	0.12285	0.1982	15	6.075	0.34247	0.57513	24	7.0055	0.12755	0.29683
"201"	"Glycerophospholipid metabolism"	90	-0.35969	0.46605	0.75193	0.35969	0.55676	1	10.957	0.32998	0.43583	43	8.0857	0.58872	0.76435	47	7.4277	0.32058	0.53658
"202"	"Glycerolipid metabolism"	56	-0.28683	0.45025	0.73219	0.28683	0.56749	1	8.6664	0.38002	0.49356	30	5.1904	0.80825	0.90782	26	7.1434	0.12402	0.29533
"203"	"Glutathione metabolism"	55	-3.955	0.92394	1	4.1256	0.072905	0.5071	15.387	0.00038881	0.001281	17	11.455	0.0047561	0.01729	38	10.85	0.0039218	0.028547
"204"	"Glutamatergic synapse"	110	-1.9742	0.71357	0.95858	1.9745	0.31227	1	11.75	0.39819	0.50932	47	8.3031	0.63566	0.79522	63	8.3539	0.33461	0.54145
"205"	"Glucagon signaling pathway"	95	-0.10567	0.41453	0.69847	0.21242	0.5934	1	17.565	0.0003401	0.0011325	45	12.831	0.038626	0.09398	50	12.039	0.003765	0.028058
"206"	"Glioma"	62	6.1888	0.0042931	0.013997	-6.1889	0.99619	1	16.542	0.00017302	0.00066044	40	13.605	0.010345	0.031846	22	9.425	0.0070884	0.043503
"207"	"Gastric acid secretion"	70	-2.6321	0.80648	1	2.6321	0.2124	0.93635	10.629	0.22826	0.32773	30	6.7425	0.57197	0.75148	40	8.2218	0.12802	0.29683
"208"	"Gap junction"	84	6.825	0.0022824	0.0079377	-6.5448	0.99714	1	15.256	0.0061016	0.014468	43	16.157	0.00062828	0.0028976	41	5.2902	0.64915	0.80949
"209"	"Galactose metabolism"	31	-0.30282	0.4977	0.7599	0.30282	0.51773	1	13.112	0.00068816	0.0021539	16	8.9292	0.055772	0.12766	15	9.6272	0.0021706	0.020588
"210"	"GABAergic synapse"	83	0.45696	0.3484	0.6161	-0.45661	0.67176	1	8.8871	0.63611	0.72931	39	7.4568	0.63181	0.79361	44	5.1857	0.70951	0.86719
"211"	"Fructose and mannose metabolism"	34	-0.28856	0.48046	0.75604	0.28856	0.53798	1	9.4136	0.079664	0.13853	18	6.1862	0.41276	0.64091	16	7.1612	0.036691	0.14537
"212"	"FoxO signaling pathway"	128	1.7134	0.1704	0.35321	-1.7136	0.84279	1	21.474	1.4063e-05	7.216e-05	66	16.202	0.0079279	0.025518	62	14.139	0.00043478	0.0059168
"213"	"Folate biosynthesis"	12	-4.8682	0.97261	1	4.8682	0.028089	0.24422	6.8517	0.076623	0.13398	3	3.0144	0.36192	0.59804	9	6.1712	0.047515	0.17705
"214"	"Focal adhesion"	196	19.366	0	0	-18.421	1	1	34.636	0	0	116	34.825	0	0	80	12.279	0.023224	0.10849
"215"	"Fluid shear stress and atherosclerosis"	138	11.303	4.6308e-07	3.1509e-06	-11.113	1	1	26.226	8.364e-10	2.1816e-08	80	24.587	2.276e-08	3.0578e-07	58	11.578	0.013545	0.067877
"216"	"Ferroptosis"	38	4.3579	0.036366	0.098979	-4.3579	0.9661	1	13.094	0.0024979	0.0067401	22	11.339	0.0096599	0.030151	16	6.8834	0.049662	0.18215
"217"	"Fc gamma R-mediated phagocytosis"	84	18.008	3.2163e-13	9.1519e-12	-17.788	1	1	24.709	7.2764e-12	2.8469e-10	61	24.556	4.2846e-10	1.1123e-08	23	7.2303	0.079047	0.23563
"218"	"Fc epsilon RI signaling pathway"	63	9.3079	3.1786e-05	0.00014013	-9.3082	0.99997	1	16.051	0.0003124	0.0010629	37	16.574	9.9706e-05	0.00057054	26	5.2148	0.43867	0.62269
"219"	"Fatty acid metabolism"	51	-6.7797	0.99417	1	6.7797	0.0074969	0.081642	13.116	0.006061	0.014468	18	5.5347	0.52406	0.72944	33	12.218	0.00024784	0.0036939
"220"	"Fatty acid elongation"	26	-3.2799	0.88546	1	3.2799	0.12301	0.704	6.2291	0.35177	0.45927	11	2.2033	0.81087	0.90782	15	6.3143	0.10829	0.28013
"221"	"Fatty acid degradation"	47	-9.3176	0.99989	1	9.3176	0.00014707	0.003288	11.064	0.042571	0.081248	11	3.0429	0.7014	0.83359	36	10.96	0.0036612	0.02795
"222"	"Fatty acid biosynthesis"	12	-0.24044	0.51905	0.76672	0.24044	0.48799	1	5.0559	0.25992	0.35998	6	3.2897	0.45456	0.67039	6	3.8604	0.21129	0.40823
"223"	"Fat digestion and absorption"	36	-1.1684	0.61901	0.86496	1.1684	0.39419	1	5.7784	0.59775	0.69552	17	3.4556	0.82425	0.91616	19	4.6852	0.385	0.58004
"224"	"Fanconi anemia pathway"	48	-2.1488	0.76339	0.99665	2.1488	0.25337	1	5.7125	0.76956	0.84993	21	2.8084	0.93278	0.99048	27	5.14	0.44345	0.62522
"225"	"Ether lipid metabolism"	41	-1.2281	0.63518	0.87583	1.2281	0.3803	1	6.3681	0.59416	0.69393	19	4.0553	0.75612	0.87205	22	4.9248	0.41104	0.60686
"226"	"Estrogen signaling pathway"	94	8.854	9.0879e-05	0.00037428	-8.5002	0.99987	1	19.415	5.4412e-05	0.00023987	53	18.884	5.3742e-05	0.00033213	41	7.9275	0.17074	0.35193
"227"	"ErbB signaling pathway"	84	7.0598	0.0017076	0.0061433	-6.8941	0.99812	1	19.939	2.0164e-06	1.2375e-05	48	17.69	3.1439e-05	0.00019826	36	10.03	0.013634	0.067877
"228"	"Epstein-Barr virus infection"	199	15.824	3.5785e-12	7.0004e-11	-15.568	1	1	24.298	3.2429e-05	0.0001586	126	24.682	8.6632e-06	6.8639e-05	73	7.6915	0.56722	0.73062
"229"	"Endometrial cancer"	49	2.8773	0.082501	0.19416	-2.8776	0.92181	1	15.094	0.00031696	0.0010668	26	12.292	0.011478	0.034192	23	8.9626	0.010822	0.058402
"230"	"Endocytosis"	267	16.644	1.3186e-12	2.7515e-11	-16.417	1	1	30.056	1.261e-08	1.716e-07	164	29.461	1.6655e-08	2.3392e-07	103	11.216	0.21802	0.4161
"231"	"Endocrine resistance"	92	9.1563	7.1617e-05	0.00029888	-8.9739	0.9999	1	18.32	0.0001555	0.00061387	58	16.682	0.0019063	0.0075518	34	8.3468	0.082988	0.2392
"232"	"Endocrine and other factor-regulated calcium reabsorption"	48	1.4365	0.23601	0.45044	-1.4365	0.77625	1	6.9529	0.57594	0.68026	22	7.3519	0.2906	0.51167	26	2.6844	0.8767	0.95281
"233"	"EGFR tyrosine kinase inhibitor resistance"	78	6.6794	0.0020185	0.0071794	-6.6796	0.9982	1	18.084	4.9744e-05	0.00022565	50	14.852	0.0072275	0.023759	28	10.335	0.0047606	0.031704
"234"	"ECM-receptor interaction"	82	7.8654	0.00037653	0.0014918	-6.9521	0.99876	1	18.151	0.00010197	0.00042716	40	19.165	1.0586e-06	9.3458e-06	42	6.6588	0.39913	0.59489
"235"	"Drug metabolism - other enzymes"	49	0.11437	0.41587	0.69847	0.76405	0.45504	1	8.6849	0.29146	0.38985	19	8.716	0.097848	0.20568	29	5.7588	0.38546	0.58004
"236"	"Drug metabolism - cytochrome P450"	64	-8.5645	0.99917	1	8.5645	0.0011171	0.017483	7.8898	0.59332	0.69393	17	1.8211	0.95072	0.99319	46	9.4097	0.076567	0.2347
"237"	"Dorso-ventral axis formation"	25	4.9179	0.019816	0.059637	-2.3055	0.85471	1	10.814	0.0064554	0.015192	16	9.2312	0.042546	0.10191	9	5.7154	0.075613	0.2347
"238"	"Dopaminergic synapse"	125	-0.55975	0.48068	0.75604	0.56003	0.55061	1	17.127	0.0090087	0.020582	56	13.086	0.080713	0.17564	69	11.262	0.04162	0.15961
"239"	"Dilated cardiomyopathy"	86	1.2258	0.21843	0.42654	-1.0845	0.77898	1	18.981	9.9026e-06	5.4313e-05	39	16.276	0.00022555	0.0011813	46	12.177	0.0025838	0.02167
"240"	"DNA replication"	34	-1.9939	0.73895	0.98422	1.9939	0.27984	1	6.4883	0.45161	0.56093	16	3.0567	0.82838	0.91745	18	6.0354	0.16004	0.34546
"241"	"D-Glutamine and D-glutamate metabolism"	2	0.02217	0.49714	0.7599	-0.02217	0.50783	1	1.1487	0.57322	0.67961	1	0.83205	0.57395	0.75148	1	0.79253	0.53325	0.70035
"242"	"D-Arginine and D-ornithine metabolism"	1	-0.15728	0.50266	0.76006	0.15728	0.49999	1	-1.1505	0.83236	0.89552	0	NA	NA	NA	1	-1.1505	0.85306	0.93555
"243"	"Cytosolic DNA-sensing pathway"	49	11.716	1.2985e-07	9.4522e-07	-11.716	1	1	14.028	0.0016433	0.0045924	34	15.21	0.00048633	0.0023119	15	2.4537	0.74155	0.87908
"244"	"Cytokine-cytokine receptor interaction"	234	21.376	0	0	-20.218	1	1	28.03	6.4038e-08	6.9117e-07	142	32.056	8.7974e-13	3.8834e-11	91	5.7652	0.95326	0.99789
"245"	"Cysteine and methionine metabolism"	45	-4.8038	0.96532	1	4.8038	0.039592	0.30981	12.797	0.0059905	0.014423	20	5.8405	0.53295	0.73456	25	11.945	9.8228e-05	0.0020497
"246"	"Complement and coagulation cascades"	85	10.608	3.9184e-06	2.1146e-05	-9.9297	0.99999	1	19.335	1.0748e-05	5.7017e-05	53	19.19	3.1386e-05	0.00019826	32	6.8163	0.23557	0.44152
"247"	"Colorectal cancer"	59	4.502	0.020885	0.061094	-4.5023	0.98088	1	14.67	0.0015731	0.0044359	33	12.555	0.01761	0.048154	26	7.9537	0.057559	0.20473
"248"	"Collecting duct acid secretion"	25	-3.1189	0.86922	1	3.1189	0.13757	0.73368	3.5559	0.78418	0.86055	9	0.63512	0.92573	0.98638	16	3.9685	0.43846	0.62269
"249"	"Cocaine addiction"	46	-0.39118	0.49375	0.7599	0.39118	0.52491	1	9.554	0.15038	0.24015	21	7.0301	0.34581	0.5776	25	6.5165	0.17551	0.35718
"250"	"Citrate cycle (TCA cycle)"	29	-14.342	1	1	14.342	7.2899e-09	3.2596e-07	14.251	4.855e-05	0.00022347	3	1.1692	0.67813	0.8255	26	14.654	2.1823e-07	6.8306e-06
"251"	"Circadian rhythm"	29	-0.80795	0.56993	0.81086	0.80795	0.4419	1	7.324	0.22411	0.32448	13	5.2591	0.3845	0.62863	16	5.1197	0.22825	0.43037
"252"	"Circadian entrainment"	94	-3.239	0.85629	1	3.2394	0.15824	0.78651	11.78	0.26675	0.36781	36	8.2923	0.4521	0.67039	58	8.464	0.25538	0.46745
"253"	"Chronic myeloid leukemia"	70	11.744	1.789e-07	1.2726e-06	-11.744	1	1	18.735	8.1626e-06	4.5623e-05	50	17.412	0.00017212	0.00093309	20	7.5197	0.041815	0.15961
"254"	"Cholinergic synapse"	108	2.631	0.094376	0.2172	-2.6309	0.91376	1	14.943	0.038894	0.075614	54	12.809	0.089581	0.19223	54	8.3236	0.24849	0.46022
"255"	"Choline metabolism in cancer"	96	3.159	0.056774	0.13992	-3.1591	0.94544	1	14.194	0.045217	0.085259	57	10.469	0.43284	0.64926	39	9.6132	0.028923	0.12933
"256"	"Chemokine signaling pathway"	178	19.579	4.4409e-16	1.7375e-14	-18.934	1	1	27.682	9.5018e-10	2.2877e-08	112	30.122	5.8575e-13	3.62e-11	65	7.2875	0.58879	0.75221
"257"	"Chemical carcinogenesis"	90	-6.738	0.99401	1	6.8413	0.0068506	0.079416	8.2277	0.78632	0.86055	27	4.1274	0.88605	0.95397	62	8.2318	0.37019	0.56799
"258"	"Chagas disease (American trypanosomiasis)"	99	12.215	5.0837e-08	4.1873e-07	-12.215	1	1	19.113	6.7922e-05	0.00029123	62	19.85	1.3203e-05	9.6894e-05	37	5.5674	0.53138	0.70035
"259"	"Central carbon metabolism in cancer"	61	10.968	1.7205e-06	1.0559e-05	-10.757	1	1	20.814	2.7082e-08	3.1395e-07	41	19.01	3.7676e-06	3.0637e-05	20	9.1315	0.0051223	0.033401
"260"	"Cell cycle"	119	3.4866	0.049853	0.12483	-3.4866	0.95433	1	15.816	0.027356	0.054193	66	12.588	0.2104	0.3847	53	9.653	0.077235	0.2347
"261"	"Cell adhesion molecules (CAMs)"	147	10.648	1.911e-06	1.1503e-05	-10.314	1	1	13.029	0.47872	0.58991	86	15.09	0.091001	0.19393	61	2.309	0.99687	1
"262"	"Cardiac muscle contraction"	71	-8.7477	0.99967	1	8.9034	0.00039395	0.0072534	14.296	0.0097689	0.021998	23	6.7583	0.45995	0.67039	47	14.04	7.4252e-05	0.0016601
"263"	"Carbon metabolism"	111	-9.2979	0.99985	1	9.3963	0.00019975	0.0041682	23.583	1.6054e-08	2.0937e-07	40	12.538	0.032324	0.07927	71	20.076	5.528e-10	3.4605e-08
"264"	"Carbohydrate digestion and absorption"	42	0.40691	0.38592	0.66737	-0.40691	0.62834	1	7.4778	0.38801	0.49978	21	6.1752	0.49472	0.70446	21	4.4	0.4975	0.67069
"265"	"Calcium signaling pathway"	173	-3.0834	0.83424	1	3.237	0.17377	0.84986	14.321	0.42856	0.53871	83	8.0245	0.95784	0.99654	90	12.15	0.050049	0.18215
"266"	"Caffeine metabolism"	4	-0.16027	0.51661	0.76672	0.16027	0.49184	1	3.8861	0.21124	0.31042	2	2.6315	0.36081	0.59804	2	2.8643	0.21125	0.40823
"267"	"Butanoate metabolism"	25	-8.7536	0.9996	1	8.7536	0.00044564	0.0077491	8.0975	0.1036	0.17332	3	2.4858	0.4524	0.67039	22	7.714	0.05417	0.19489
"268"	"Breast cancer"	141	4.6619	0.010453	0.032718	-4.662	0.99148	1	14.421	0.19604	0.2908	81	11.833	0.50648	0.71581	60	8.3578	0.31056	0.52626
"269"	"Bladder cancer"	37	11.693	7.9362e-07	5.2852e-06	-11.228	1	1	17.487	1.1158e-06	7.276e-06	28	16.102	1.3484e-05	9.6894e-05	9	7.0537	0.016879	0.082549
"270"	"Biotin metabolism"	2	-3.3097	0.90597	1	3.3097	0.10025	0.61525	2.9243	0.26809	0.36803	0	NA	NA	NA	2	2.9243	0.20224	0.40064
"271"	"Biosynthesis of unsaturated fatty acids"	27	-0.21027	0.50251	0.76006	0.21027	0.51162	1	5.2787	0.53842	0.65068	14	3.3101	0.7668	0.8757	13	4.1723	0.36188	0.56432
"272"	"Biosynthesis of amino acids"	73	0.71139	0.31291	0.57274	-0.40942	0.66057	1	17.411	5.0503e-05	0.00022582	37	12.444	0.028069	0.070429	36	12.178	0.00047832	0.006238
"273"	"Bile secretion"	68	-2.3691	0.7699	0.99665	2.3695	0.24602	1	10.753	0.19106	0.28672	29	6.3478	0.64366	0.79876	39	8.7255	0.074888	0.2347
"274"	"Base excision repair"	32	-0.38809	0.52595	0.76672	0.38809	0.48768	1	3.9447	0.82373	0.89214	18	1.9809	0.94433	0.99319	14	3.7176	0.48182	0.65285
"275"	"Basal transcription factors"	41	-0.30013	0.48796	0.7599	0.30013	0.52762	1	6.9614	0.49046	0.60202	21	4.8217	0.72369	0.84705	20	5.0265	0.33193	0.54145
"276"	"Basal cell carcinoma"	53	0.97178	0.29085	0.53868	-0.97178	0.72403	1	3.4993	0.96486	1	29	2.1807	0.9849	0.9975	24	2.8031	0.83729	0.92605
"277"	"Bacterial invasion of epithelial cells"	66	20.657	0	0	-20.154	1	1	24.943	1.2745e-13	9.9732e-12	52	25.008	2.9428e-12	1.1366e-10	14	5.9619	0.12342	0.29533
"278"	"B cell receptor signaling pathway"	68	10.279	6.1532e-06	3.0571e-05	-10.279	0.99999	1	16.736	0.00021859	0.00079557	46	15.4	0.0024181	0.009458	22	7.1539	0.092015	0.24832
"279"	"Axon guidance"	171	7.3733	0.00084959	0.0031658	-7.2719	0.99922	1	23.753	6.2388e-06	3.5504e-05	97	20.105	0.00080672	0.0036127	74	13.089	0.0072452	0.04361
"280"	"Autophagy - other"	30	-1.9611	0.76357	0.99665	1.9611	0.25422	1	7.1142	0.28604	0.38425	13	4.332	0.56055	0.74457	17	5.6625	0.20906	0.40823
"281"	"Autophagy - animal"	126	1.366	0.2194	0.42654	-1.2854	0.78928	1	18.188	0.0017966	0.0049763	61	14.415	0.04035	0.097408	65	11.358	0.034927	0.14126
"282"	"Autoimmune thyroid disease"	50	2.28	0.1395	0.29704	-2.2815	0.86823	1	-0.18508	0.9997	1	26	1.4797	0.98369	0.9975	24	-1.8072	0.99953	1
"283"	"Asthma"	19	1.9424	0.18559	0.37721	-1.9424	0.82004	1	1.1574	0.94083	0.99487	11	1.9139	0.84199	0.9226	8	-0.46058	0.9403	0.99106
"284"	"Ascorbate and aldarate metabolism"	26	-0.93933	0.6053	0.84959	0.93933	0.40787	1	2.0646	0.9271	0.98702	9	3.3952	0.60586	0.78004	16	2.1378	0.78318	0.90274
"285"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	70	0.77081	0.29299	0.53945	-0.7708	0.72425	1	13.949	0.013739	0.029863	32	12.192	0.01722	0.047509	37	9.197	0.04234	0.15967
"286"	"Arginine biosynthesis"	18	1.5195	0.24428	0.4634	-1.5195	0.7606	1	6.697	0.16061	0.25136	11	4.7498	0.42521	0.64724	7	4.785	0.12618	0.29683
"287"	"Arginine and proline metabolism"	47	0.4408	0.36493	0.64035	-0.21573	0.61984	1	16.084	3.5693e-05	0.00017188	21	12.414	0.0024666	0.0095273	26	10.469	0.0019833	0.020025
"288"	"Arachidonic acid metabolism"	83	-2.4148	0.77469	0.99785	2.5218	0.23121	0.99137	5.7791	0.95621	1	29	4.6729	0.86245	0.93181	54	3.7404	0.94468	0.99223
"289"	"Apoptosis - multiple species"	30	4.3865	0.026858	0.075058	-4.3865	0.97331	1	11.872	0.003924	0.0098256	16	11.188	0.0051158	0.01817	14	5.4186	0.18708	0.37535
"290"	"Apoptosis"	132	13.543	1.5109e-09	1.6308e-08	-13.543	1	1	25.036	2.3903e-09	4.1566e-08	77	25.564	4.3196e-10	1.1123e-08	55	8.537	0.19305	0.38488
"291"	"Apelin signaling pathway"	136	6.8087	0.0013274	0.0048309	-6.451	0.99816	1	20.551	0.00017087	0.00066028	75	18.353	0.0012864	0.0052999	61	10.336	0.069134	0.2331
"292"	"Antigen processing and presentation"	71	4.3947	0.02057	0.060739	-4.1965	0.9764	1	6.6699	0.83592	0.89604	35	8.3729	0.39588	0.63381	36	1.1111	0.9904	1
"293"	"Antifolate resistance"	29	6.4622	0.0025639	0.008723	-6.4615	0.99759	1	11.496	0.0040351	0.0099448	16	12.43	0.00095107	0.0041983	13	3.38	0.51564	0.68778
"294"	"Amyotrophic lateral sclerosis (ALS)"	50	2.8155	0.097909	0.2189	-2.8155	0.90778	1	11.256	0.047867	0.089715	23	10.863	0.028263	0.070429	27	5.2921	0.4134	0.60749
"295"	"Amphetamine addiction"	63	-0.60981	0.52822	0.76672	0.60981	0.49139	1	13.194	0.015618	0.033255	27	10.189	0.06697	0.14995	36	8.6306	0.067616	0.23257
"296"	"Amoebiasis"	94	14.783	5.3078e-10	6.1531e-09	-13.835	1	1	22.324	1.6322e-07	1.5026e-06	57	23.864	9.0908e-10	2.1608e-08	37	5.9638	0.45298	0.63163
"297"	"Aminoacyl-tRNA biosynthesis"	43	-0.56955	0.52909	0.76672	0.56955	0.48861	1	12.843	0.0039783	0.0098826	18	11.151	0.0091246	0.02877	25	7.3817	0.084192	0.23957
"298"	"Amino sugar and nucleotide sugar metabolism"	48	3.1121	0.082183	0.19416	-3.1121	0.92291	1	9.1297	0.22169	0.32274	29	7.6191	0.42833	0.6479	19	5.0982	0.31105	0.52626
"299"	"Alzheimers disease"	160	-16.102	1	1	16.26	1.5943e-10	9.9804e-09	25.056	1.2462e-07	1.219e-06	39	10.897	0.12241	0.24885	121	22.626	7.0081e-10	3.6559e-08
"300"	"Allograft rejection"	47	2.3133	0.13129	0.28341	-2.3149	0.87889	1	0.24329	0.99912	1	25	1.5697	0.98489	0.9975	22	-1.3177	0.99792	1
"301"	"Aldosterone-regulated sodium reabsorption"	36	0.12811	0.4173	0.69847	-0.12811	0.5944	1	7.2792	0.3314	0.43583	14	7.6064	0.12971	0.25973	22	3.2438	0.72819	0.87438
"302"	"Aldosterone synthesis and secretion"	83	-0.49624	0.49604	0.7599	0.49624	0.52687	1	9.5812	0.51767	0.62803	39	7.1245	0.68492	0.82717	44	6.4518	0.46953	0.6435
"303"	"Alcoholism"	177	-1.7673	0.64767	0.88912	1.7675	0.38934	1	9.7829	0.97008	1	66	11.869	0.31373	0.53858	105	8.0988	0.78914	0.90463
"304"	"Alanine, aspartate and glutamate metabolism"	35	-3.3486	0.88454	1	3.3486	0.12371	0.704	9.624	0.070481	0.12534	17	3.9141	0.7672	0.8757	18	9.6163	0.0031896	0.025599
"305"	"African trypanosomiasis"	32	7.7406	0.00062366	0.0023806	-7.7399	0.99937	1	7.6602	0.22041	0.32238	21	9.4902	0.066799	0.14995	11	-0.047334	0.9404	0.99106
"306"	"Adrenergic signaling in cardiomyocytes"	140	-1.9544	0.69811	0.9482	2.0649	0.31239	1	19.361	0.0015045	0.0043202	62	14.564	0.032248	0.07927	77	13.973	0.0024151	0.021598
"307"	"Adipocytokine signaling pathway"	70	2.4679	0.10607	0.23547	-2.4675	0.90154	1	15.12	0.0032654	0.0084998	33	13.359	0.0071351	0.023707	37	8.1804	0.11139	0.28345
"308"	"Adherens junction"	70	10.147	4.7375e-06	2.4309e-05	-9.9125	0.99999	1	19.017	4.6326e-06	2.6852e-05	43	18.236	1.9383e-05	0.00013309	27	7.6057	0.083299	0.2392
"309"	"Acute myeloid leukemia"	54	6.723	0.0013014	0.0047924	-6.7233	0.99863	1	13.582	0.0034047	0.008664	34	12.454	0.019459	0.051408	20	6.0799	0.16307	0.34726
"310"	"AMPK signaling pathway"	121	0.31832	0.3436	0.61106	-0.31832	0.68066	1	17.698	0.0031068	0.008241	60	12.761	0.13372	0.26486	61	12.271	0.0062316	0.039806
"311"	"AGE-RAGE signaling pathway in diabetic complications"	99	12.371	3.5725e-08	3.0221e-07	-12.195	1	1	22.372	7.2347e-08	7.5482e-07	61	22.103	1.96e-07	2.0188e-06	38	8.1061	0.10732	0.28013
"312"	"ABC transporters"	44	-8.4332	0.999	1	8.4332	0.001258	0.01875	12.202	0.0097224	0.021998	11	4.9577	0.3913	0.63304	33	11.228	0.0014924	0.016459
"313"	"2-Oxocarboxylic acid metabolism"	17	-6.6498	0.99627	1	6.6498	0.004635	0.055798	7.3105	0.08897	0.15217	3	1.5058	0.62312	0.78745	14	7.3587	0.032128	0.13776
